vs

Side-by-side financial comparison of CHEGG, INC (CHGG) and CASTLE BIOSCIENCES INC (CSTL). Click either name above to swap in a different company.

CASTLE BIOSCIENCES INC is the larger business by last-quarter revenue ($83.7M vs $72.7M, roughly 1.2× CHEGG, INC). On growth, CASTLE BIOSCIENCES INC posted the faster year-over-year revenue change (-4.9% vs -49.4%). Over the past eight quarters, CASTLE BIOSCIENCES INC's revenue compounded faster (-1.9% CAGR vs -35.4%).

Chegg, Inc., is an American educational technology company based in Santa Clara, California. It provides homework help, digital and physical textbook rentals, textbooks, online tutoring, and other student services, powered by artificial intelligence. The company has 6.6 million subscribers. Chegg has been widely criticized for facilitating cheating and academic dishonesty among students.

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

CHGG vs CSTL — Head-to-Head

Bigger by revenue
CSTL
CSTL
1.2× larger
CSTL
$83.7M
$72.7M
CHGG
Growing faster (revenue YoY)
CSTL
CSTL
+44.5% gap
CSTL
-4.9%
-49.4%
CHGG
Faster 2-yr revenue CAGR
CSTL
CSTL
Annualised
CSTL
-1.9%
-35.4%
CHGG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CHGG
CHGG
CSTL
CSTL
Revenue
$72.7M
$83.7M
Net Profit
$-14.5M
Gross Margin
57.3%
Operating Margin
-47.2%
Net Margin
-17.4%
Revenue YoY
-49.4%
-4.9%
Net Profit YoY
43.8%
EPS (diluted)
$-0.30
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHGG
CHGG
CSTL
CSTL
Q1 26
$83.7M
Q4 25
$72.7M
$87.0M
Q3 25
$77.7M
$83.0M
Q2 25
$105.1M
$86.2M
Q1 25
$121.4M
$88.0M
Q4 24
$143.5M
$86.3M
Q3 24
$136.6M
$85.8M
Q2 24
$163.1M
$87.0M
Net Profit
CHGG
CHGG
CSTL
CSTL
Q1 26
$-14.5M
Q4 25
Q3 25
$-17.5M
$-501.0K
Q2 25
$-35.7M
$4.5M
Q1 25
$-17.5M
$-25.8M
Q4 24
Q3 24
$-212.6M
$2.3M
Q2 24
$-616.9M
$8.9M
Gross Margin
CHGG
CHGG
CSTL
CSTL
Q1 26
Q4 25
57.3%
79.0%
Q3 25
59.2%
77.5%
Q2 25
66.3%
79.5%
Q1 25
55.5%
81.4%
Q4 24
68.2%
81.3%
Q3 24
68.2%
81.8%
Q2 24
72.2%
83.3%
Operating Margin
CHGG
CHGG
CSTL
CSTL
Q1 26
Q4 25
-47.2%
-4.4%
Q3 25
-22.0%
-8.2%
Q2 25
-34.7%
-4.9%
Q1 25
-23.9%
-31.7%
Q4 24
-19.0%
4.7%
Q3 24
-162.7%
5.9%
Q2 24
-297.3%
5.8%
Net Margin
CHGG
CHGG
CSTL
CSTL
Q1 26
-17.4%
Q4 25
Q3 25
-22.5%
-0.6%
Q2 25
-33.9%
5.2%
Q1 25
-14.4%
-29.4%
Q4 24
Q3 24
-155.7%
2.6%
Q2 24
-378.1%
10.3%
EPS (diluted)
CHGG
CHGG
CSTL
CSTL
Q1 26
$-0.49
Q4 25
$-0.30
$-0.06
Q3 25
$-0.16
$-0.02
Q2 25
$-0.33
$0.15
Q1 25
$-0.17
$-0.90
Q4 24
$-0.03
$0.32
Q3 24
$-2.05
$0.08
Q2 24
$-6.01
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHGG
CHGG
CSTL
CSTL
Cash + ST InvestmentsLiquidity on hand
$72.8M
$63.8M
Total DebtLower is stronger
$10.1M
Stockholders' EquityBook value
$119.6M
$461.4M
Total Assets
$278.0M
$547.8M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHGG
CHGG
CSTL
CSTL
Q1 26
$63.8M
Q4 25
$72.8M
$299.5M
Q3 25
$96.4M
$287.5M
Q2 25
$85.6M
$275.9M
Q1 25
$88.3M
$275.2M
Q4 24
$315.7M
$293.1M
Q3 24
$361.1M
$95.0M
Q2 24
$345.5M
$85.6M
Total Debt
CHGG
CHGG
CSTL
CSTL
Q1 26
$10.1M
Q4 25
$10.1M
Q3 25
$10.0M
Q2 25
$10.0M
Q1 25
$10.0M
Q4 24
$10.0M
Q3 24
$10.0M
Q2 24
$10.0M
Stockholders' Equity
CHGG
CHGG
CSTL
CSTL
Q1 26
$461.4M
Q4 25
$119.6M
$470.9M
Q3 25
$146.1M
$467.0M
Q2 25
$157.9M
$455.4M
Q1 25
$185.7M
$440.3M
Q4 24
$193.0M
$455.8M
Q3 24
$185.0M
$441.1M
Q2 24
$365.5M
$423.9M
Total Assets
CHGG
CHGG
CSTL
CSTL
Q1 26
$547.8M
Q4 25
$278.0M
$578.6M
Q3 25
$378.3M
$562.8M
Q2 25
$404.5M
$544.7M
Q1 25
$438.8M
$501.7M
Q4 24
$869.0M
$531.2M
Q3 24
$1.0B
$514.6M
Q2 24
$1.1B
$487.3M
Debt / Equity
CHGG
CHGG
CSTL
CSTL
Q1 26
0.02×
Q4 25
0.02×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHGG
CHGG
CSTL
CSTL
Operating Cash FlowLast quarter
$-9.0M
$-22.1M
Free Cash FlowOCF − Capex
$-15.5M
FCF MarginFCF / Revenue
-21.3%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHGG
CHGG
CSTL
CSTL
Q1 26
$-22.1M
Q4 25
$-9.0M
$26.9M
Q3 25
$4.8M
$22.6M
Q2 25
$-4.8M
$20.8M
Q1 25
$24.5M
$-6.0M
Q4 24
$18.1M
$24.4M
Q3 24
$39.5M
$23.3M
Q2 24
$14.2M
$24.0M
Free Cash Flow
CHGG
CHGG
CSTL
CSTL
Q1 26
Q4 25
$-15.5M
$19.7M
Q3 25
$-943.0K
$7.8M
Q2 25
$-12.1M
$11.6M
Q1 25
$15.9M
$-10.8M
Q4 24
$4.8M
$16.8M
Q3 24
$23.7M
$17.0M
Q2 24
$-3.6M
$18.8M
FCF Margin
CHGG
CHGG
CSTL
CSTL
Q1 26
Q4 25
-21.3%
22.7%
Q3 25
-1.2%
9.4%
Q2 25
-11.5%
13.4%
Q1 25
13.1%
-12.2%
Q4 24
3.4%
19.5%
Q3 24
17.3%
19.8%
Q2 24
-2.2%
21.6%
Capex Intensity
CHGG
CHGG
CSTL
CSTL
Q1 26
Q4 25
8.9%
8.3%
Q3 25
7.4%
17.9%
Q2 25
6.9%
10.7%
Q1 25
7.1%
5.4%
Q4 24
9.3%
8.8%
Q3 24
11.6%
7.4%
Q2 24
10.9%
6.0%
Cash Conversion
CHGG
CHGG
CSTL
CSTL
Q1 26
Q4 25
Q3 25
Q2 25
4.60×
Q1 25
Q4 24
Q3 24
10.29×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons